US10959949 — Composition and method for vancomycin oral liquid
Method of Use · Assigned to Azurity Pharmaceuticals Inc · Expires 2035-03-13 · 9y remaining
What this patent protects
This patent protects a stable vancomycin hydrochloride powder for oral liquid formulations and methods of using those formulations to treat certain diseases.
USPTO Abstract
The invention relates to stable vancomycin hydrochloride powder for oral liquid formulations. Also provided herein are methods of using vancomycin oral liquid formulations for the treatment of certain diseases such as Clostridium difficile pseudomembranous colitis and Staphylococcal enterocolitis as well as kits and related products thereof.
Drugs covered by this patent
FDA Patent Use Codes
When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.
| Code | Description | Drug |
|---|---|---|
U-3104 |
— | vancomycin-hydrochloride |
U-3105 |
— | vancomycin-hydrochloride |
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.